Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials.
- 1 April 2001
- Vol. 57 (4) , 174-177
- https://doi.org/10.1016/s0090-4295(00)00967-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Age-Specific Reference Ranges for Prostate Specific Antigen in Young Men: Retrospective Study from the National Defense UniversityThe Prostate Journal, 2001
- Prostate-specific antigen levels in young white and black men 20 to 45 years oldUrology, 2000
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, 1999
- Issues in Prostate Cancer ScreeningJAMA, 1999
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black MenNew England Journal of Medicine, 1996
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerPublished by American Medical Association (AMA) ,1995
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992